Copper Complexation by 3-Hydroxypyridin-4-one Iron Chelators: Structural and Iron Competition Studies

1994 ◽  
Vol 37 (4) ◽  
pp. 461-466 ◽  
Author(s):  
Ali El-Jammal ◽  
P. Lynne Howell ◽  
Mary A. Turner ◽  
Naiyin Li ◽  
Douglas M. Templeton
Keyword(s):  
Iron Chelators ◽  
Copper Complexation ◽  
Iron Competition

Iono-molecular Separation with Composite Membranes II. Preparation and characterization of polysulphone and composite nanoparticles

2017 ◽  
Vol 68 (2) ◽  
pp. 203-209
Author(s):  
Hussam Nadum Abdalraheem Al Ani ◽  
Anca Maria Cimbru ◽  
Corneliu Trisca-Rusu ◽  
Szidonia Katalin Tanczos ◽  
Adriana Cuciureanu ◽  
...  
Keyword(s):  
Chemical Species ◽  
Composite Membranes ◽  
Ammonium Persulfate ◽  
Operating Pressure ◽  
Polysulfone Membrane ◽  
Polymeric Nanoparticle ◽  
Molecular Separation ◽  
Copper Complexation ◽  
Molecular Separations ◽  
Methyl Pyrrolidone

This paper illustrates the possibility of producing iono-molecular separations using ionic colloidal ultrafiltration membrane of polysulfone synthetic solutions of cupric ions and nitro phenols through ultrafiltration assisted by polymeric nanoparticle composites based on polysulfone. In the present work, in order to reduce the operating pressure and increase the flow of water we are using the process of ultrafiltration through a polysulfone membrane in N-methylpyrrolidone 10% prepared by coagulation in isopropanol. The nanoparticles needed in colloidal ultrafiltration had been obtained through the immersion technique of precipitation of a solution of 5% PSf in N-methyl pyrrolidone containing 3% aniline in lower alcohols: methanol, ethanol, and isopropanol, followed by the oxidation of the remaining aniline in a solution of 10% hydrochloric acid and ammonium persulfate. The Nanoparticles of polysulfone (NP-PSf) and The three obtained variants of nanoparticles composites (NP-PSf-PANI) were morphologically (SEM) and (AFM), structurally and compositionally (FTIR) characterized and the results show that nanoparticles polysulfone have a much lower range than the composites. The Possibility of copper complexation by both nitrophenols, and by nanoparticle surface probably lead to the formation of more stable aggregates in the supply, which can sufficiently justify the increased retention. The Retentions of the chemical species in question use in all the tests made the same series:R NP-PSf-PANI-M] R NP-PSf-PANI-E] R NP-PSf-PANI-P] R NP-PSf

Therapeutic Macromolecular Iron Chelators

2019 ◽  
Vol 26 (2) ◽  
pp. 323-334 ◽  
Author(s):  
Upendra Bulbake ◽  
Alka Singh ◽  
Abraham J. Domb ◽  
Wahid Khan
Keyword(s):  
Iron Overload ◽  
Chelation Therapy ◽  
Iron Chelator ◽  
Therapeutic Agents ◽  
Iron Chelators ◽  
Low Molecular Weight ◽  
Research Findings ◽  
Pharmaceutical Properties ◽  
Single Living ◽  
Living Process

Iron is a key element for every single living process. On a fundamental level, targeting iron is a valuable approach for the treatment of disorders caused by iron overload. Utilizing iron chelators as therapeutic agents has received expanding consideration in chelation therapy. Approved low molecular weight (MW) iron chelators to treat iron overload may experience short half-lives and toxicities prompting moderately high adverse effects. In recent years, polymeric/macromolecular iron chelators have received attention as therapeutic agents. Polymeric iron chelators show unique pharmaceutical properties that are different to their conventional small molecule counterparts. These polymeric iron chelators possess longer plasma half-lives and reduced toxicities, thus exhibiting a significant supplement to currently using low MW iron chelator therapy. In this review, we have briefly discussed polymeric iron chelators and factors to be considered when designing clinically valuable iron chelators. We have also discussed applications of polymeric iron chelators in the diseases caused by iron overload associated with transfusional hemosiderosis, neurodegenerative disorders, malaria and cancer. With this, research findings for new polymeric iron chelators are also covered.

Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer

2014 ◽  
Vol 15 (12) ◽  
pp. 1125-1140 ◽  
Author(s):  
Mohsin Raza ◽  
Sankalpa Chakraborty ◽  
Monjoy Choudhury ◽  
Prahlad Ghosh ◽  
Alo Nag
Keyword(s):  
Iron Homeostasis ◽  
Iron Chelators ◽  
Therapeutic Implications ◽  
Cellular Iron ◽  
Cellular Iron Homeostasis

Iron chelators for acute stroke

2011 ◽  
Author(s):  
Junpeng Ma ◽  
Chao You ◽  
Li Hao
Keyword(s):  
Acute Stroke ◽  
Iron Chelators

scholarly journals In vitro activities of novel catecholate siderophores against Plasmodium falciparum.

1996 ◽  
Vol 40 (9) ◽  
pp. 2094-2098 ◽  
Author(s):  
B Pradines ◽  
F Ramiandrasoa ◽  
L K Basco ◽  
L Bricard ◽  
G Kunesch ◽  
...  
Keyword(s):  
Plasmodium Falciparum ◽  
Mechanism Of Action ◽  
Ribonucleotide Reductase ◽  
Antimalarial Activity ◽  
Iron Chelators ◽  
Resistant Clone ◽  
Iron Deprivation ◽  
Level Of Activity ◽  
Susceptible Clone

The activities of novel iron chelators, alone and in combination with chloroquine, quinine, or artemether, were evaluated in vitro against susceptible and resistant clones of Plasmodium falciparum with a semimicroassay system. N4-nonyl,N1,N8-bis(2,3-dihydroxybenzoyl) spermidine hydrobromide (compound 7) demonstrated the highest level of activity: 170 nM against a chloroquine-susceptible clone and 1 microM against a chloroquine-resistant clone (50% inhibitory concentrations). Compounds 6, 8, and 10 showed antimalarial activity with 50% inhibitory concentrations of about 1 microM. Compound 7 had no effect on the activities of chloroquine, quinine, and artemether against either clone, and compound 8 did not enhance the schizontocidal action of either chloroquine or quinine against the chloroquine-resistant clone. The incubation of compound 7 with FeCI3 suppressed or decreased the in vitro antimalarial activity of compound 7, while no effect was observed with incubation of compound 7 with CuSO4 and ZnSO4. These results suggest that iron deprivation may be the main mechanism of action of compound 7 against the malarial parasites. Chelator compounds 7 and 8 primarily affected trophozoite stages, probably by influencing the activity of ribonucleotide reductase, and thus inhibiting DNA synthesis.

Multifunctional iron-chelators with protective roles against neurodegenerative diseases

2013 ◽  
Vol 42 (17) ◽  
pp. 6058 ◽  
Author(s):  
Andreia Nunes ◽  
Sérgio M. Marques ◽  
Catarina Quintanova ◽  
Diana F. Silva ◽  
Sandra M. Cardoso ◽  
...  
Keyword(s):  
Neurodegenerative Diseases ◽  
Iron Chelators

scholarly journals Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms

2021 ◽  
Vol 137 ◽  
pp. 111380
Author(s):  
Jian Zhang ◽  
Hai Zhao ◽  
Gang Yao ◽  
Penghai Qiao ◽  
Longfei Li ◽  
...  
Keyword(s):  
Therapeutic Potential ◽  
Iron Chelators ◽  
Cellular Mechanisms

Development of an HPLC method for measuring orally administered 1-substituted 2-alkyl-3-hydroxypyrid-4-one iron chelators in biological fluids

1990 ◽  
Vol 36 (1) ◽  
pp. 5-8 ◽  
Author(s):  
J G Goddard ◽  
G J Kontoghiorghes
Keyword(s):  
High Performance ◽  
Biological Fluids ◽  
Internal Standard ◽  
High Performance Liquid Chromatographic ◽  
Reversed Phase ◽  
Hplc Method ◽  
Iron Chelators ◽  
Serum Samples ◽  
Thalassemic Patient ◽  
Serum And Urine

Abstract "High-performance" liquid-chromatographic (HPLC) methods have been developed for identifying 1-substituted 2-alkyl-3-hydroxypyrid-4-one iron chelators in serum and urine. Ion pairing with heptane- or octanesulfonic acid in pH 2.0-2.2 phosphate buffer and reversed-phase chromatography were required to separate these compounds from endogenous compounds in both biological fluids. In both the 2-methyl and 2-ethyl series of 1-substituted compounds (H, methyl, ethyl, or propyl) the elution times increased in accordance with the n-octanol/water partition coefficients (propyl greater than ethyl greater than H greater than methyl). Urine samples were filtered (0.4 microns pore size) and injected either undiluted or after dilution with elution buffer. After the addition of internal standard, the plasma or serum samples were deproteinized by treatment with HCIO4, 0.5 mol/L, centrifuged, and the supernates were injected directly onto the HPLC. Using these procedures, we could identify 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in the serum and urine of a thalassemic patient who had received a 3-g dose of the drug and in the urine of other patients who had received the same dose. One or more possible metabolites were also observed in the chromatograms of both urine and serum. The 24-h urinary output of L1 (0.22-2.37 g) and iron (10.6-71.5 mg) varied but there was no correlation between the two with respect to quantity or concentration. Instead, urinary iron output was higher in patients with a greater number of transfused units of erythrocytes. This is the first study in humans to show that L1 is absorbed from the gut, enters the circulation, and is excreted in the urine.

scholarly journals Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells

2015 ◽  
Vol 1850 (11) ◽  
pp. 2256-2264 ◽  
Author(s):  
Andres A. Caro ◽  
Ava Commissariat ◽  
Caroline Dunn ◽  
Hyunjoo Kim ◽  
Salvador Lorente García ◽  
...  
Keyword(s):  
Hepg2 Cells ◽  
Antioxidant Properties ◽  
Iron Chelators
Sign in / Sign up

Export Citation Format

Share Document